Doctor profile · Federal record
Dr. KATELYN LYNE, NP-C
Nurse Practitioner · Family Nurse Practitioner · COLONIAL HEIGHTS, VA
- NPI 1588258768
- Accepts Medicare
- 6 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
Operates at 2 locations .
- Primary practice
-
445 CHARLES H DIMMOCK PKWY STE 100
COLONIAL HEIGHTS, VA 238342990
(804) 520-1764
fax (804) 616-4221 - Additional location
-
7101 Jahnke Rd Ste 550
Richmond, VA 232254017
(804) 560-8880 - Mailing address
-
15612 NEW GALE DR
MIDLOTHIAN, VA 231125018
Credentials & registration
- NPI registered
- February 2021 — 5 yrs on file
- Profile last updated
- September 18, 2024
- Year of graduation
- 2020 — 6 yrs since
- Specialty taxonomy
- 363L00000X — NUCC code
- State license (1)
- Virginia #0024181020
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1588258768. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
91
Distinct HCPCS
3
Medicare allowed
$5,669
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 33 | 32 | $74 | |
93000 |
Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 31 | 31 | $12 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 27 | 26 | $106 |
In context: peer comparison
Among 5 peers in this city , average services per provider: 57. This provider delivers 1.6× the peer median.Open Payments
Industry payments received
All-time total
$819
Transactions
36
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | 6 | $174.12 | |
| Kiniksa Pharmaceuticals International, plc | 3 | $65.32 | |
| Boston Scientific Corporation | 2 | $64.59 | |
| Amgen Inc. | 3 | $63.94 | |
| Esperion Therapeutics, Inc. | 3 | $54.69 | |
| Janssen Pharmaceuticals, Inc | 3 | $50.50 | |
| SCPHARMACEUTICALS INC. | 2 | $43.83 | |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $41.46 | |
| AstraZeneca Pharmaceuticals LP | 2 | $40.40 | |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 2 | $38.42 | |
| PFIZER INC. | 2 | $37.31 | |
| Alnylam Pharmaceuticals Inc. | 2 | $30.80 | |
| Merck Sharp & Dohme LLC | 2 | $29.55 | |
| Actelion Pharmaceuticals US, Inc. | 1 | $19.44 | |
| Lexicon Pharmaceuticals, Inc. | 1 | $18.23 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
656
Patients
210
Total drug cost
$157,801
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Atorvastatin Calcium | Generic | 99 | 39 | $1,175 |
| Amlodipine Besylate | Generic | 86 | 27 | $641 |
| Losartan Potassium | Generic | 54 | 21 | $348 |
| Metoprolol Succinate | Generic | 49 | 20 | $849 |
| Xarelto (Rivaroxaban) | Brand | 46 | 12 | $49,432 |
| Rosuvastatin Calcium | Generic | 41 | 14 | $881 |
| Clopidogrel (Clopidogrel Bisulfate) | Brand | 39 | 16 | $526 |
| Eliquis (Apixaban) | Brand | 39 | 19 | $52,608 |
| Metoprolol Tartrate | Generic | 35 | 16 | $201 |
| Lisinopril | Generic | 33 | 14 | $222 |